clopidogrel and 4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide

clopidogrel has been researched along with 4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, H; Chen, VM; Connor, D; Hogg, PJ; Kritharides, L; Lau, E; Lau, JK; Liang, HP; Muller, D; Pasalic, L; Pennings, GJ; Wing-Lun, E1

Other Studies

1 other study(ies) available for clopidogrel and 4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide

ArticleYear
Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:6

    Topics: Aged; Arsenicals; Aspirin; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Resistance; Female; Flow Cytometry; Glutathione; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests

2018